AIM2 and neoplasm: This means that persistent inflammation induced by AIM2 overexpression attracts immunosuppressive cells, including regulatory T cells (Tregs) [159,160], myeloid-derived suppressor cells (MDSCs) [161], and tumor-associated macrophages (TAMs) [162] at the tumor site.